E

Eiko Lifesciences Ltd

EIKO
Market snapshot · 2026-08-11 01:16 UTC

49.16

+₹0.50 (+1.03%)

MARKET CAP

₹71.21 Cr

STOCK P/E

15.4x

52W HIGH

₹64.44

52W LOW

₹45.90

BOOK VALUE

₹47.94

EPS

₹3.19

ROE

8.40%

SECTOR

Basic Materials

DEBT/EQUITY

6.78

VOLUME

8,855

P/B RATIO

1.03x

PEG RATIO

Sector

Basic Materials

Themes

Specialty Chemicals
₹56.35₹54.43₹52.50₹50.58₹48.66VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 10.7% below historical median. Valuation is stable — currently in the strongly undervalued zone (z-score: -1.24). Confidence: 90%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Undervalued

5Y Average

17.24

Current

15.25

Overvalued

18.44

Undervalued

16.02

EV/EBITDA
Strongly Undervalued

5Y Average

9.43

Current

8.43

Overvalued

10.43

Undervalued

8.51

P/B
Strongly Undervalued

5Y Average

1.23

Current

1.03

Overvalued

1.41

Undervalued

1.05

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹16 CrMar 2026

Latest net profit

₹1.12 CrMar 2026

Latest EPS

₹0.78Mar 2026

Net margin

7.7%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%3.0%6.0%9.0%12.0%0.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr₹0₹0₹0₹1₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr4.00 Cr8.00 Cr12 Cr16 Cr

Latest reported period: Mar 2026

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +6.596.516.416.618.4010.757.746.917.097.459.209.5715.90
Expenses +6.236.246.066.147.8910.357.396.466.586.928.478.7014.67
Operating Profit0.360.270.350.470.510.400.350.450.510.530.730.871.23
OPM %5.46%4.15%5.46%7.11%6.07%3.72%4.52%6.51%7.19%7.11%7.93%9.09%7.74%
Other Income +0.210.030.030.010.110.260.130.100.870.550.560.560.45
Interest0.030.030.060.030.020.030.040.020.040.020.070.040.04
Depreciation0.160.160.160.160.180.170.160.150.150.150.150.150.15
Profit before tax0.380.110.160.290.420.460.280.381.190.911.071.241.49
Tax %26.32%27.27%25.00%17.24%26.19%26.09%28.57%26.32%25.21%24.18%23.36%23.39%24.83%
Net Profit +0.280.080.120.240.310.350.210.280.900.690.820.951.12
EPS in Rs0.200.060.090.170.270.280.170.220.720.500.600.690.78
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Loading shareholding pattern...

Events Timeline

Board Meeting Intimation for Meeting Scheduled To Be Held On 12Th August, 2026

Aug 07, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 13, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 24, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

May 27, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Change in Management

May 26, 2026PDFCompany Reports Open